Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 22;12(2):e001597.
doi: 10.1136/lupus-2025-001597.

Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data

Iñigo Rua-Figueroa  1 , Ricard Cervera  2 , Mercedes Freire-González  3 , Ana Isabel Turrión Nieves  4 , Josefina Cortés-Hernández  5 , Iván Castellvi  6 , Julia Barbado Ajo  7 , Tarek Salman  8 , Jaime Calvo Alén  9 , Nuria Lozano-Rivas  10 , Norberto Ortego-Centeno  11 , Monserrat Diaz-Encarnación  12 , Bo Ding  13 , Marta Galvez-Fernandez  14 , Noemí Bahamontes-Rosa  14 , José María Pego-Reigosa  15 ; Spanish SLE Prospective Observational Cohort Study (SPOCS)
Collaborators, Affiliations

Oral glucocorticoid patterns use in moderate to severe active SLE: insights from the Spanish SPOCS data

Iñigo Rua-Figueroa et al. Lupus Sci Med. .
No abstract available

Keywords: Glucocorticoids; Lupus Erythematosus, Systemic; Patient Reported Outcome Measures.

PubMed Disclaimer

Conflict of interest statement

Competing interests: RC reports collaborations with the following companies: AstraZeneca, Celgene, GSK, Janssen, ElyLilly, Pfizer, UCB, Rubió, Menarini, Werfen, Alpine and Roche. BD is a full-time employee of AstraZeneca Sweden. MG-F and NB-R are full-time employees of AstraZeneca Spain. Other authors do not declare conflict of interest.

References

    1. Fanouriakis A, Kostopoulou M, Andersen J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15–29. doi: 10.1136/ard-2023-224762. - DOI - PubMed
    1. Aringer M, Arnaud L, Furie RA, et al. Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS) Lupus Sci Med. 2025;12:e001336. doi: 10.1136/lupus-2024-001336. - DOI - PMC - PubMed
    1. Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:736–45. doi: 10.1136/annrheumdis-2019-215089. - DOI - PubMed

LinkOut - more resources